F, C., AC, S., MS, H., & FA, F. (2023). Editorial: Adjuvanted recombinant zoster vaccine in adults with inflammatory bowel disease-time for universal recommendation? Authors' reply. Alimentary pharmacology & therapeutics, 57(11), 1345. https://doi.org/10.1111/apt.17519
Chicago Style (17th ed.) CitationF, Caldera, Spaulding AC, Hayney MS, and Farraye FA. "Editorial: Adjuvanted Recombinant Zoster Vaccine in Adults with Inflammatory Bowel Disease-time for Universal Recommendation? Authors' Reply." Alimentary Pharmacology & Therapeutics 57, no. 11 (2023): 1345. https://doi.org/10.1111/apt.17519.
MLA (9th ed.) CitationF, Caldera, et al. "Editorial: Adjuvanted Recombinant Zoster Vaccine in Adults with Inflammatory Bowel Disease-time for Universal Recommendation? Authors' Reply." Alimentary Pharmacology & Therapeutics, vol. 57, no. 11, 2023, p. 1345, https://doi.org/10.1111/apt.17519.